IONS
#907
Ionis Pharmaceuticals, Inc. - Common Stock
60.3 2 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.73%
Changement Mensuel
+14.55%
Evolution sur 6 mois
-24.99%
Changement Annuel
-16.37%
Clôture Précédente
59.8 8
Open
60.2 5
Low
60.2 0
High
61.7 7
Volume
253
Financials
- Market Capitalization 10.02 B
- Employee 1 402
- Founded 1989
- CEO Brett P. Monia Ph.D.
- Website www.ionis.com
- Headquarter California, United States
- FIGI BBG000JH6683
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-68.35
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 876 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 202.00 USD | -0.41% | -1.24% | -6.26% | +55.15% | 10.58 B USD | ||
| 899 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.71 USD | -0.72% | -0.13% | +6.52% | +98.54% | 10.01 B USD | ||
| 908 |  CYTK Cytokinetics, Incorporated - Common Stock | 71.93 USD | +0.74% | -7.72% | -6.21% | +23.80% | 10.00 B USD | ||
| 911 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 118.81 USD | -0.20% | -4.47% | +15.61% | +101.03% | 9.88 B USD |